Literature DB >> 18656897

MicroRNAs in solid tumors.

Mary Dillhoff1, Sylwia E Wojcik, Mark Bloomston.   

Abstract

MicroRNAs (miRNAs or miRs) are small, noncoding RNAs (approximately 20-22 nucleotides) that have critical functions in cell proliferation, apoptosis, and differentiation. These evolutionarily conserved RNA sequences are the result of a complex sequence of processing steps, which can regulate the expression of tens, and even hundreds, of genes. Their regulatory effect is based upon the degree of complementarity between the mature miRNA and the 3' untranslated region region of the target mRNA resulting in either complete degradation or translational inhibition of the target mRNA. In vertebrates they are often tissue specific in their expression patterns and dysregulated in malignancies. Thus, miRNA profiling has been used to create signatures for many solid malignancies. These profiles have been used to not only classify tumors, but also to help predict survival and outcome. Herein, we review the role of miRNAs in the development and progression of solid tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18656897      PMCID: PMC4069197          DOI: 10.1016/j.jss.2008.02.046

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  46 in total

1.  Argonaute2, a link between genetic and biochemical analyses of RNAi.

Authors:  S M Hammond; S Boettcher; A A Caudy; R Kobayashi; G J Hannon
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

2.  High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma.

Authors:  Markus Metzler; Monika Wilda; Kerstin Busch; Susanne Viehmann; Arndt Borkhardt
Journal:  Genes Chromosomes Cancer       Date:  2004-02       Impact factor: 5.006

3.  MicroRNA maturation: stepwise processing and subcellular localization.

Authors:  Yoontae Lee; Kipyoung Jeon; Jun-Tae Lee; Sunyoung Kim; V Narry Kim
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

Review 4.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

5.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

6.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  The nuclear RNase III Drosha initiates microRNA processing.

Authors:  Yoontae Lee; Chiyoung Ahn; Jinju Han; Hyounjeong Choi; Jaekwang Kim; Jeongbin Yim; Junho Lee; Patrick Provost; Olof Rådmark; Sunyoung Kim; V Narry Kim
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

8.  Reduced accumulation of specific microRNAs in colorectal neoplasia.

Authors:  Michael Z Michael; Susan M O' Connor; Nicholas G van Holst Pellekaan; Graeme P Young; Robert J James
Journal:  Mol Cancer Res       Date:  2003-10       Impact factor: 5.852

9.  Nuclear export of microRNA precursors.

Authors:  Elsebet Lund; Stephan Güttinger; Angelo Calado; James E Dahlberg; Ulrike Kutay
Journal:  Science       Date:  2003-11-20       Impact factor: 47.728

10.  A microRNA in a multiple-turnover RNAi enzyme complex.

Authors:  György Hutvágner; Phillip D Zamore
Journal:  Science       Date:  2002-08-01       Impact factor: 47.728

View more
  21 in total

1.  miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts.

Authors:  Hanno Matthaei; Dennis Wylie; Maura B Lloyd; Marco Dal Molin; Jon Kemppainen; Skye C Mayo; Christopher L Wolfgang; Richard D Schulick; Laura Langfield; Bernard F Andruss; Alex T Adai; Ralph H Hruban; Anna E Szafranska-Schwarzbach; Anirban Maitra
Journal:  Clin Cancer Res       Date:  2012-06-21       Impact factor: 12.531

2.  Up-regulation of microRNA in bladder tumor tissue is not common.

Authors:  Gang Wang; Honghe Zhang; Huadong He; Wenjuan Tong; Bin Wang; Guodong Liao; Zhaodian Chen; Caigan Du
Journal:  Int Urol Nephrol       Date:  2009-05-28       Impact factor: 2.370

Review 3.  MicroRNAs: Key Players in Bladder Cancer.

Authors:  Qi Li; Helei Wang; Hourong Peng; Qiuping Huang; Ting Huyan; Qingsheng Huang; Hui Yang; Junling Shi
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

Review 4.  The impact of cellular senescence in cancer therapy: is it true or not?

Authors:  Yi Zhang; Jin-ming Yang
Journal:  Acta Pharmacol Sin       Date:  2011-09-12       Impact factor: 6.150

5.  Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.

Authors:  Imran Bhatti; Andrew Lee; Victoria James; Richard I Hall; Jonathan N Lund; Cristina Tufarelli; Dileep N Lobo; Michael Larvin
Journal:  J Gastrointest Surg       Date:  2010-11-19       Impact factor: 3.452

6.  The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence.

Authors:  Lixin Hong; Maoyi Lai; Michelle Chen; Changchuan Xie; Rong Liao; Young Jun Kang; Changchun Xiao; Wen-Yuan Hu; Jiahuai Han; Peiqing Sun
Journal:  Cancer Res       Date:  2010-09-17       Impact factor: 12.701

Review 7.  MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.

Authors:  Muzafar A Macha; Parthasarathy Seshacharyulu; Shiv Ram Krishn; Priya Pai; Satyanarayana Rachagani; Maneesh Jain; Surinder K Batra
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

8.  Differential Expression of MicroRNAs in Tissues and Plasma Co-exists as a Biomarker for Pancreatic Cancer.

Authors:  Shadan Ali; Hala Dubaybo; Randall E Brand; Fazlul H Sarkar
Journal:  J Cancer Sci Ther       Date:  2015

9.  Circulating microRNAs, potential biomarkers for drug-induced liver injury.

Authors:  Kai Wang; Shile Zhang; Bruz Marzolf; Pamela Troisch; Amy Brightman; Zhiyuan Hu; Leroy E Hood; David J Galas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

10.  MicroRNAs and Gastroenterological Cancers.

Authors:  Anuradha Budhu; Xin W Wang
Journal:  Drug Discov Today Dis Mech       Date:  2011-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.